Cite
Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis.
MLA
Kim, Chang Seong, et al. “Glycol Chitosan-Based Tacrolimus-Loaded Nanomicelle Therapy Ameliorates Lupus Nephritis.” Journal of Nanobiotechnology, vol. 19, no. 1, Apr. 2021, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12951-021-00857-w.
APA
Kim, C. S., Mathew, A. P., Vasukutty, A., Uthaman, S., Joo, S. Y., Bae, E. H., Ma, S. K., Park, I.-K., & Kim, S. W. (2021). Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. Journal of Nanobiotechnology, 19(1), 1–17. https://doi.org/10.1186/s12951-021-00857-w
Chicago
Kim, Chang Seong, Ansuja Pulickal Mathew, Arathy Vasukutty, Saji Uthaman, Soo Yeon Joo, Eun Hui Bae, Seong Kwon Ma, In-Kyu Park, and Soo Wan Kim. 2021. “Glycol Chitosan-Based Tacrolimus-Loaded Nanomicelle Therapy Ameliorates Lupus Nephritis.” Journal of Nanobiotechnology 19 (1): 1–17. doi:10.1186/s12951-021-00857-w.